Serum anti-Müllerian hormone (AMH) levels are a reliable and valuable indicator of ovarian reserve and are often reduced in patients with EMs and inversely correlated with disease severity (Muzii et al. 2018). This evidence concerns the gene AMH and eosinophilia-myalgia syndrome.